A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis.

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease in which approximately 40% of the patients respond well to current chemotherapy, but the prognosis for the other 60% is poor. The Leukemia/Lymphoma Molecular Profiling Project (LLMPP) used microarray technology to define a molecular profile for each of 240 patients with DLBCL and develop a molecular outcome predictor score that accurately predicted patient survival. Data from our laboratory and others suggest that alterations in antioxidant defense enzyme levels and redox environment can be oncogenic and affect the response to glucocorticoid treatment, one of the components of combination chemotherapy regimens for lymphoma. The goal of the current study was to reanalyze the LLMPP microarray data to determine whether the levels of antioxidant defense enzymes and redox proteins were correlated with prognosis in DLBCL. We found that patients with DLBCL with the worst prognosis, according to the outcome predictor score, had decreased expression of catalase, glutathione peroxidase, manganese superoxide dismutase, and VDUP1, a protein that inhibits thioredoxin activity. The data suggest that the patients with the worst prognosis combine a decrease in antioxidant defense enzyme expression with an increase in thioredoxin system function (the redox signature score).

[1]  G. Fiskum,et al.  Bcl-2 family proteins regulate mitochondrial reactive oxygen production and protect against oxidative stress. , 2004, Free radical biology & medicine.

[2]  T. Herman,et al.  Enhanced topoisomerase II targeting by annamycin and related 4-demethoxy anthracycline analogues. , 2004, Molecular cancer therapeutics.

[3]  E. Rosen,et al.  BRCA1 Induces Antioxidant Gene Expression and Resistance to Oxidative Stress , 2004, Cancer Research.

[4]  Joy Joseph,et al.  Doxorubicin Induces Apoptosis in Normal and Tumor Cells via Distinctly Different Mechanisms , 2004, Journal of Biological Chemistry.

[5]  L. Staudt,et al.  Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project. , 2004, Blood.

[6]  Leah E. Mechanic,et al.  p53-Induced Up-Regulation of MnSOD and GPx but not Catalase Increases Oxidative Stress and Apoptosis , 2004, Cancer Research.

[7]  J. Crapo,et al.  Superoxide dismutases in malignant cells and human tumors. , 2004, Free radical biology & medicine.

[8]  Y. Ishii,et al.  Loss of Thioredoxin-Binding Protein-2/Vitamin D3 Up-Regulated Protein 1 in Human T-Cell Leukemia Virus Type I-Dependent T-Cell Transformation , 2004, Cancer Research.

[9]  J. Voigt,et al.  Expression of a vitamin D-regulated gene (VDUP-1) in untreated- and MNU-treated rat mammary tissue , 1998, Breast Cancer Research and Treatment.

[10]  G. Powis,et al.  Reversible inhibition of human thioredoxin reductase activity by cytotoxic alkyl 2-imidazolyl disulfide analogues , 2004, Cancer Chemotherapy and Pharmacology.

[11]  T. Golub,et al.  A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer , 2003, Cell.

[12]  Jun Ho Jeon,et al.  VDUP1 upregulated by TGF-β1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression , 2003, Oncogene.

[13]  T. Grogan,et al.  Gene Expression Profile of Serial Samples of Transformed B-Cell Lymphomas , 2003, Laboratory Investigation.

[14]  L. Freedman,et al.  Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. , 2003, Cancer research.

[15]  本多 幸.  Correlation of urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG), a biomarker of oxidative DNA damage, and clinical features of hematological disorders : A pilot study , 2003 .

[16]  R. Bowler,et al.  Effects of metalloporphyrin catalytic antioxidants in experimental brain ischemia. , 2002, Free radical biology & medicine.

[17]  Aftab Ahmad,et al.  Elevated expression of hexokinase II protects human lung epithelial-like A549 cells against oxidative injury. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[18]  Dean P. Jones,et al.  Glutathione depletion enforces the mitochondrial permeability transition and causes cell death in HL60 cells that overexpress Bcl‐2 , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  Y. Awasthi,et al.  Role of α Class Glutathione S-Transferases as Antioxidant Enzymes in Rodent Tissues , 2002 .

[20]  P. Gaulard,et al.  p53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomas. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  S. Barrans,et al.  Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma. , 2002, Blood.

[22]  Y. Awasthi,et al.  Role of alpha class glutathione S-transferases as antioxidant enzymes in rodent tissues. , 2002, Toxicology and applied pharmacology.

[23]  Meland,et al.  The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.

[24]  Todd,et al.  Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning , 2002, Nature Medicine.

[25]  W. E. Fahl,et al.  Functional characterization of transcription regulators that interact with the electrophile response element. , 2001, Biochemical and biophysical research communications.

[26]  T. Tanaka,et al.  Thioredoxin expression in primary T-cell acute lymphoblastic leukemia and its therapeutic implication. , 2001, Cancer research.

[27]  M. Briehl,et al.  Thymocytes selected for resistance to hydrogen peroxide show altered antioxidant enzyme profiles and resistance to dexamethasone-induced apoptosis , 2001, Cell Death and Differentiation.

[28]  M. Mirault,et al.  Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells. , 2001, Molecular pharmacology.

[29]  Freya Q. Schafer,et al.  Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. , 2001, Free radical biology & medicine.

[30]  E. May,et al.  Reciprocal down-regulation of p53 and SOD2 gene expression–implication in p53 mediated apoptosis , 2001, Oncogene.

[31]  G. Powis,et al.  Properties and biological activities of thioredoxins. , 2001, Annual review of biophysics and biomolecular structure.

[32]  Elias S. J. Arnér,et al.  Physiological functions of thioredoxin and thioredoxin reductase. , 2000, European journal of biochemistry.

[33]  T. Galeotti,et al.  Deregulated manganese superoxide dismutase expression and resistance to oxidative injury in p53-deficient cells. , 2000, Cancer research.

[34]  G Chelvanayagam,et al.  Identification, Characterization, and Crystal Structure of the Omega Class Glutathione Transferases* , 2000, The Journal of Biological Chemistry.

[35]  E. Shacter,et al.  Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis and phagocytosis. , 2000, Blood.

[36]  M. Tomonaga,et al.  Correlation of urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG), a biomarker of oxidative DNA damage, and clinical features of hematological disorders: a pilot study. , 2000, Leukemia research.

[37]  M. Kelner,et al.  Structural Organization of the Microsomal Glutathione S-Transferase Gene (MGST1) on Chromosome 12p13.1–13.2 , 2000, The Journal of Biological Chemistry.

[38]  D. Ann,et al.  Oxidative Stress Disrupts Glucocorticoid Hormone-dependent Transcription of the Amiloride-sensitive Epithelial Sodium Channel α-Subunit in Lung Epithelial Cells through ERK-dependent and Thioredoxin-sensitive Pathways* , 2000, The Journal of Biological Chemistry.

[39]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[40]  P. Talalay.  Chemoprotection against cancer by induction of phase 2 enzymes. , 2000, BioFactors.

[41]  Y. Ho,et al.  NF-kappaB is required for cytokine-induced manganese superoxide dismutase expression in insulin-producing cells. , 2000, Endocrinology.

[42]  D. Voehringer,et al.  Redox aspects of Bcl-2 function. , 2000, Antioxidants & redox signaling.

[43]  Y. Ho,et al.  NF-κB Is Required for Cytokine-Induced Manganese Superoxide Dismutase Expression in Insulin-Producing Cells1. , 2000, Endocrinology.

[44]  L. Oberley,et al.  Comparison of effects of two polymorphic variants of manganese superoxide dismutase on human breast MCF-7 cancer cell phenotype. , 1999, Cancer research.

[45]  L. Oberley,et al.  The role of antioxidant enzymes in the control of opossum gallbladder motility. , 1999, The Journal of surgical research.

[46]  K. Davies,et al.  Nitric oxide enhances the manganese superoxide dismutase-dependent suppression of proliferation in HT-1080 fibrosarcoma cells. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[47]  M. Matsui,et al.  Identification of Thioredoxin-binding Protein-2/Vitamin D3 Up-regulated Protein 1 as a Negative Regulator of Thioredoxin Function and Expression* , 1999, The Journal of Biological Chemistry.

[48]  K. Umesono,et al.  Redox-dependent Regulation of Nuclear Import of the Glucocorticoid Receptor* , 1999, The Journal of Biological Chemistry.

[49]  D. Gewirtz,et al.  A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. , 1999, Biochemical pharmacology.

[50]  A. Hirvonen.  Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. , 1999, Environmental health perspectives.

[51]  J. Kleinjans,et al.  Human health risk assessment: A case study involving heavy metal soil contamination after the flooding of the river Meuse during the winter of 1993-1994. , 1999, Environmental health perspectives.

[52]  H. Kamata,et al.  Redox regulation of cellular signalling. , 1999, Cellular signalling.

[53]  Kleanthis G. Xanthopoulos,et al.  Biological Role of the CCAAT/Enhancer-binding Protein Family of Transcription Factors* , 1998, The Journal of Biological Chemistry.

[54]  L. Oberley,et al.  Use of commercial antibodies for detection of the primary antioxidant enzymes. , 1998, Free radical biology & medicine.

[55]  S. Cory,et al.  The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.

[56]  T. Graf,et al.  Distinct C/EBP functions are required for eosinophil lineage commitment and maturation. , 1998, Genes & development.

[57]  L. Oberley,et al.  Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has multiple effects on cell phenotype , 1998, The Prostate.

[58]  Kohei Miyazono,et al.  Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.

[59]  G. Powis,et al.  Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo. , 1997, Cancer research.

[60]  J C Reed,et al.  Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. , 1997, Blood.

[61]  L. Oberley,et al.  Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase , 1997, Oncogene.

[62]  K. Umesono,et al.  Thioredoxin: a redox-regulating cellular cofactor for glucocorticoid hormone action. Cross talk between endocrine control of stress response and cellular antioxidant defense system. , 1996, The Journal of clinical investigation.

[63]  P. Musiani,et al.  Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice , 1996, The Journal of experimental medicine.

[64]  K. Davies.  Oxidative stress: the paradox of aerobic life. , 1995, Biochemical Society symposium.

[65]  D. S. St. Clair,et al.  Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase. , 1995, Oncogene.

[66]  H. Steinman.  The Bcl-2 oncoprotein functions as a pro-oxidant. , 1995, Journal of Biological Chemistry.

[67]  J. Hayes,et al.  The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. , 1995, Critical reviews in biochemistry and molecular biology.

[68]  S. Marklund,et al.  Immunocytochemical localization of extracellular superoxide dismutase in human lung. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[69]  J. Crapo,et al.  Copper,zinc superoxide dismutase is primarily a cytosolic protein in human cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[70]  J. Yodoi,et al.  Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[71]  L. Oberley,et al.  Immunohistochemical localization of antioxidant enzymes in adult Syrian hamster tissues and during kidney development. , 1990, The American journal of pathology.

[72]  Y. Sun,et al.  Free radicals, antioxidant enzymes, and carcinogenesis. , 1990, Free radical biology & medicine.

[73]  P. Cerutti.  Prooxidant states and tumor promotion. , 1985, Science.

[74]  I. Fridovich,et al.  Mitochondrial superoxide simutase. Site of synthesis and intramitochondrial localization. , 1973, The Journal of biological chemistry.